Not able to join us for the event?

Disappointed to miss out on what is sure to be 2 days of insightful content from some of the world’s leading thought leaders in your industry?

Don’t worry we have you covered with:

Cparity Event Live +

Complete access to all speaker presentations from our key industry leaders
Connect live to the entire event or simply select the specific presentations you wish to join on the day
Take part in event polling and position questions to our expert speakers, feel truly connected to the event
Download all event content and additional associated resources distributed to attendees
On-Demand Content hosted post event for 6months provides a great internal resource for you and your team

Simply complete your registration form and you will recieve an email confirmation with login details to the event APP. our team will continue to provide updates and reminders as the event approaches so you won’t miss a thing.

Our content, your way!

Solentim is the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, including cell and gene therapies, monoclonal antibodies, vaccines and stem cells. For our customers, which include most of the world’s leading pharmaceutical and biotherapeutics companies, we are the partner of choice for facilitating the highest level of assurance in cell line development for therapeutic protein and viral vector production.

Our customers develop cell and antibody based therapies for a wide range of conditions including lymphomas, cancers, Crohn’s disease, rheumatoid arthritis, high cholesterol and asthma.

Our portfolio of proven and innovative instruments (including VIPS™, Cell Metric^®,Cell Metric^® CLD, ICON™ and STUDIUS™) are designed for single cell cloning and assurance of monoclonality. Combined with enabling reagents and our unparalleled domain expertise, we transform the speed and efficiency of clonally-derived Master Cell Bank development. Our customers trust in our technology to ensure they are confidently prepared for regulatory review.

Solentim continues to define modern assurance driven workflows for cell based and antibody based biotherapeutics including stem cells, gene therapy and immunotherapy.

VISIT THE WEBSITE: https://www.solentim.com/